Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T CellsKeisuke Watanabe(Saitama Red Cross Hospital), Makoto Murata(Nagoya University)The Journal of ImmunologyDecember 18, 201410.4049/jimmunol.1402346Cited by 283SaveCiteExport RISWatch citationsRelated PapersAn NK-like CAR T cell transition in CAR T cell dysfunction|Cell|2021|398Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses|JCI Insight|2018|279Biological significance of HLA locus matching in unrelated donor bone marrow transplantation|Blood|2014|162